Financials Zhejiang Hisun Biomaterials Co.Ltd.

Equities

688203

CNE100005PR6

Specialty Chemicals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-16 EDT 5-day change 1st Jan Change
8.57 CNY -0.81% Intraday chart for Zhejiang Hisun Biomaterials Co.Ltd. -1.04% -34.18%

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 3,172 2,639
Enterprise Value (EV) 1 2,506 2,041
P/E ratio 56.2 x 62 x
Yield 0.45% 0.61%
Capitalization / Revenue 5.24 x 3.5 x
EV / Revenue 4.14 x 2.71 x
EV / EBITDA 36.7 x 22.8 x
EV / FCF -16,329,447 x -21,137,068 x
FCF Yield -0% -0%
Price to Book 2.18 x 1.78 x
Nbr of stocks (in thousands) 202,678 202,678
Reference price 2 15.65 13.02
Announcement Date 23-03-13 24-03-25
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 227.9 231.9 262.7 585 605.4 753.3
EBITDA 1 20.84 20.14 53.88 81.62 68.26 89.71
EBIT 1 16.1 14.51 42.54 45.22 26.43 36.11
Operating Margin 7.06% 6.26% 16.2% 7.73% 4.37% 4.79%
Earnings before Tax (EBT) 1 8.728 10.25 35.66 38.34 52.58 53.29
Net income 1 8.707 10.06 30.38 35.27 47.03 43.55
Net margin 3.82% 4.34% 11.57% 6.03% 7.77% 5.78%
EPS 2 0.1087 0.1100 0.3300 0.2300 0.2785 0.2100
Free Cash Flow - -92.62 -130.4 -423.2 -153.5 -96.56
FCF margin - -39.94% -49.66% -72.34% -25.35% -12.82%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - 0.0700 0.0800
Announcement Date 22-03-11 22-03-11 22-03-11 22-06-30 23-03-13 24-03-25
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 11.8 104 - 95.2 - -
Net Cash position 1 - - 173 - 666 598
Leverage (Debt/EBITDA) 0.5653 x 5.174 x - 1.167 x - -
Free Cash Flow - -92.6 -130 -423 -153 -96.6
ROE (net income / shareholders' equity) - 8.31% 8.15% 5.54% 4.47% 2.97%
ROA (Net income/ Total Assets) - 3.24% 3.56% 2.4% 1.06% 1.13%
Assets 1 - 310.2 852.4 1,467 4,429 3,840
Book Value Per Share 2 1.450 1.380 4.070 4.300 7.160 7.310
Cash Flow per Share 2 0.5800 0.5700 3.910 1.640 4.630 4.220
Capex 1 38.7 116 198 309 225 214
Capex / Sales 17% 49.88% 75.41% 52.9% 37.21% 28.42%
Announcement Date 22-03-11 22-03-11 22-03-11 22-06-30 23-03-13 24-03-25
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688203 Stock
  4. Financials Zhejiang Hisun Biomaterials Co.Ltd.